Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/002826 stock hub

SHE/002826 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002826is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.6B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002826

In the news

Latest news · SHE/002826

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E38.4

P25 23.5P50 41.3P75 83.2

ROE11.7

P25 -0.9P50 4.1P75 8.8

ROIC21.9

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002826 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

CNY

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	403
Employees Change	-36%
Employees Change Percent	-8.2
Enterprise value	CNY 3.1B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100002C39
Last refreshed	2026-05-10
Market cap	CNY 3.6B
Price	CNY 19.17
Price currency	CNY
Rev Per Employee	1,663,319.57x
Sector	Healthcare
Sic	2834
Symbol	she/002826
Website	https://www.emyy.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.6%
EV Earnings	32.79x
EV/EBIT	47.41x
EV/EBITDA	36.64x
EV/FCF	18.75x
EV/Sales	4.81x
FCF yield	4.55%
P/B ratio	4.28x
P/E ratio	38.42x
P/S ratio	5.36x
PE Ratio10 Y	58.27x
PE Ratio3 Y	55.75x
PE Ratio5 Y	51.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.1%
EBITDA Margin	12.84%
FCF margin	24.37%
Gross margin	82.71%
Gross Profit	CNY 554.4M
Gross Profit Growth	18.38%
Gross Profit Growth Q	26.94%
Gross Profit Growth3 Y	14.39%
Gross Profit Growth5 Y	17.56%
Net Income	CNY 93.4M
Net Income Growth	153.74%
Net Income Growth Q	4.55%
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Net Income Growth3 Y	28.56%
Net Income Growth5 Y	18.27%
Pretax Margin	17.54%
Profit Margin	13.94%
Profit Per Employee	CNY 231,849
Profitable Years	13
ROA	4.05
Roa5y	2.75
ROCE	8.04
ROE	11.69
Roe5y	6.56
ROIC	21.88
Roic5y	8.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	62.37%
Cagr3y	21.87%
Cagr5y	15.61%
Div CAGR3	0%
Div CAGR5	4.56%
EPS Growth	161.7
EPS Growth Q	10
EPS Growth Quarters	4
EPS Growth Years	2
EPS Growth3 Y	31.44
EPS Growth5 Y	18.56
FCF Growth	103%
FCF Growth Q	158.51%
FCF Growth3 Y	16.44%
FCF Growth5 Y	18.78%
OCF Growth	94.17%
OCF Growth Q	157.14%
OCF Growth10 Y	12.67%
OCF Growth3 Y	17.76%
OCF Growth5 Y	10.23%
Revenue Growth	4.74x
Revenue Growth Q	22.92x
Revenue Growth Quarters	3x
Revenue Growth Years	0x
Revenue Growth3 Y	-7.31x
Revenue Growth5 Y	0.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.64
Assets	CNY 1.1B
Cash	CNY 633.6M
Current Assets	CNY 723.3M
Current Liabilities	CNY 260.5M
Equity	CNY 838M
Interest Coverage	81.88
Liabilities	CNY 265.3M
Long Term Assets	CNY 380M
Long Term Liabilities	CNY 4.8M
Net Cash	CNY 633.6M
Net Cash By Market Cap	CNY 17.65
Net Cash Growth	38.57%
Net Debt EBITDA	CNY -7.36
Net Debt Equity	CNY -0.76
Net Debt FCF	CNY -3.88
Tangible Book Value	CNY 802.3M
Tangible Book Value Per Share	CNY 4.49
WACC	6.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.78
Inventory Turnover	2.56
Net Working Capital	CNY -170.7M
Quick ratio	2.54
Working Capital	CNY 462.8M
Working Capital Turnover	CNY 1.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.03%
Dividend Growth	233.33%
Dividend Growth Years	1%
Dividend per share	CNY 0.1
Dividend Years	9
Dividend Yield	0.52%
Ex Div Date	2025-06-24
Last Dividend	CNY 0.1
Payout Frequency	Annual
Payout Ratio	25.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	62.32%
200-day SMA	19.88
3Y total return	81.04%
50-day SMA	20.45
50-day SMA vs 200-day SMA	50over200
5Y total return	106.47%
All Time High	35.6
All Time High Change	-46.15%
All Time High Date	2017-02-28
All Time Low	5.57
All Time Low Change	244.17%
All Time Low Date	2024-02-08
ATR	0.76
Beta	0.42
Beta1y	0.17
Beta2y	0.49
Ch YTD	4.3
High	19.64
High52	26.83
High52 Date	2025-08-20
High52ch	-28.55%
Low	18.75
Low52	11.16
Low52 Date	2025-05-08
Low52ch	76.85%
Ma50ch	-6.24%
Price vs 200-day SMA	-3.56%
RSI	39.04
RSI Monthly	61.03
RSI Weekly	47.83
Sharpe ratio	1.38x
Sortino ratio	2.63
Total Return	3.55%
Tr YTD	4.3
Tr1m	-3.72%
Tr1w	-2.99%
Tr3m	-10.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 67.7M
Operating Income Growth	308.1
Operating Income Growth Q	122
Operating Income Growth3 Y	13.42
Operating Income Growth5 Y	9.55
Operating margin	10.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	121,577,116%
Net Borrowing	-35,300,442
Shares Insiders	35.08%
Shares Institutions	0.39%
Shares Out	187,273,950
Shares Yo Y	-3.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 163.4M
Average Volume	5,386,023.45x
Bv Per Share	4.69
CAPEX	CNY -8.8M
Ch1m	-3.72
Ch1w	-2.99
Ch1y	61.64
Ch3m	-10.17
Ch3y	77.99
Ch5y	99.27
Ch6m	-3.67
Change	-0.47%
Change From Open	-0.1
Close	19.26
Days Gap	-0.36
Depreciation Amortization	18,328,662
Dollar Volume	112,793,596.2
Earnings Date	2026-04-28
EBIT	CNY 67.7M
EBITDA	CNY 86.1M
EPS	CNY 0.52
F Score	5
FCF	CNY 163.4M
FCF EV Yield	5.33x
FCF Per Share	CNY 0.87
Financing CF	-27,993,788
Fiscal Year End	December
Founded	2,003
Goodwill	16,668,928
Graham Number	7.43087
Graham Upside	-61.24
Income Tax	CNY 23.7M
Investing CF	-2,090,352
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Lynch Fair Value	CNY 9.56
Lynch Upside	-50.15
Ma150	19.6
Ma150ch	-2.2%
Ma20	20.23
Ma20ch	-5.26%
Net CF	141,032,652
Next Earnings Date	2026-08-14
Open	19.19
P FCF Ratio	21.97
P OCF Ratio	20.85
Payment Date	2025-06-24
Position In Range	47.19
Ppne	327,509,990
Price Date	2026-05-08
Price EBITDA	CNY 41.72
Ptbv Ratio	4.47
Relative Volume	1.1x
Revenue	670,317,786x
Tax By Revenue	3.54x
Tax Rate	20.18%
Tr6m	-3.67%
Volume	5,883,860

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/002826 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.10 annual per share

Payout ratio

+25.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+4.6%

1 consecutive years of growth

Total shareholder yield

+3.6%

Next ex-dividend date: 2025-06-24

Performance

SHE/002826 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002826?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.4%

Share of float held by funds and institutions

Insider ownership

+35.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-3.0%

Negative means the company is buying back shares.

Technical

SHE/002826 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.0

Neutral momentum band

Price vs 200-day MA

-3.6%

50/200-day relationship not available

Beta (5Y)

0.42

Less volatile than the market

Sharpe ratio

1.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002826

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002826 stock rating?

she/002826 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002826 analysis?

The full report lives at /stocks/she/002826/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002826?

The latest report frames she/002826 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002826 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.